GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

Explore neuroscience breakthroughs reshaping treatments for Alzheimer’s, Parkinson’s, PTSD, and other brain disorders.

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

For centuries, Oxford has been synonymous with academic excellence, with its historical university shaping generations of thinkers. Nowadays, the city is also an iconic biotech hub, making up part of ...

The global market share of biologics was estimated at $400 billion in 2024 and is expected to reach over $650 billion by 2030. At this rate, the global market size of biologics could even outpace that ...